This Postgraduate certificate in Childhood Cancer will generate a sense of security in the performance of your profession, which will help you to offer a quality service to your patients"

Diseases that occur at an early age, those affecting children and young people are unique and different from tumors suffered by adults. Although the figures are optimistic in the prognosis and treatment of oncological diseases affecting children, since only 2% of cancers occur at this stage of life, it is necessary to have professionals specialized in treating childhood cancer, adapting to the real needs of the youngest.

This Postgraduate certificate in Childhood Cancer offers the possibility of specializing in the treatment of cancer in children and young people in order to acquire the excellent professional skills to treat specific diseases that occur at very early ages.

The specialization will allow the development of competencies, skills and abilities for the performance of the profession, taking into account that the patients are children who require different attention and treatment than adults.

Update your knowledge through the Postgraduate certificate in Childhood Cancer program"

This Postgraduate certificate in Childhood Cancer contains the most complete and up-to-date scientific program on the market. The most important features of the program include:

• Development of more than 75 case studies presented by experts in childhood cancer
• The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• News on Childhood Cancer
• It contains practical exercises where the self-evaluation process can be carried out to improve learning
• With special emphasis on innovative methodologies in Childhood Cancer
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This course may be the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in childhood cancer, you will obtain a Postgraduate certificate from TECH"

It includes in its teaching staff professionals belonging to the field of childhood cancer who pour into this specialization the experience of their work, in addition to recognized specialists belonging to reference societies and prestigious universities.

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training program to train in real situations.

The design of this program is based on problem-based learning, by means of which the professional must try to solve the different professional practice situations that arise throughout the course. For this purpose, the professional will be assisted by an innovative interactive video system developed by renowned experts in the field of Childhood Cancer and with great medical experience. 

Increase your confidence in decision making by updating your knowledge through this course"

Take the opportunity to learn about the latest advances in Childhood Cancer, and improve the specialization of your students"

The contents structure has been designed by a team of professionals from the best educational centers and universities in the national territory, aware of the relevance of current specialization in order to intervene in the specialization and support of students with high capacity, and committed to quality teaching through new educational technologies.

This Postgraduate certificate in Childhood Cancer contains the most complete and up-to-date scientific program on the market"

Module 1. Cancer General Aspects. Risk Factors

1.1. Introduction

1.1.1. Overview of Malignant Neoplasms

1.1.1.1. Nomenclature
1.1.1.2. Features
1.1.1.3. How Metastases Spread
1.1.1.4. Prognostic Factors

1.1.2. Epidemiology of Cancer

1.1.2.1. Incidence
1.1.2.2. Prevalence
1.1.2.3. Geographical Distribution
1.1.2.4. Risk Factors
1.1.2.5. Prevention
1.1.2.6. Early Diagnosis

1.1.3. Mutagenic Agents

1.1.3.1. Environmental
1.1.3.2. Workplace
1.1.3.3. Toxic Substances in Food

1.1.4. Biological Agents and Cancer

1.1.4.1. RNA Virus
1.1.4.2. DNA Virus
1.1.4.3. H. pylori

1.1.5. Genetic Predisposition

1.1.5.1. Genes Linked to Cancer
1.1.5.2. Susceptibility Genes

  1.1.5.2.1. Breast Tumors
  1.1.5.2.2. Lung Tumors
  1.1.5.2.3. Thyroid Tumors
  1.1.5.2.4. Colon Tumors
  1.1.5.2.5. Skin Tumors
  1.1.5.2.6. Bone Tumors
  1.1.5.2.7. Pancreas Tumors
  1.1.5.2.8. Neuroblastoma

1.1.6.  Clinical Aspects of Malignant Neoplasms
1.1.7.  Staging of neoplastic disease

Module 2. Molecular Basis of Cancer

2.1. Introduction to the Molecular Basis of Cancer

2.1.1. Genes and the Genome

2.1.1.1. The Main Cell Signaling Pathways
2.1.1.2. Cell Growth and Proliferation
2.1.1.3. Cell Death. Necrosis and Apoptosis

2.2. Mutations

2.2.1. Types of Mutations. Frameshift; Indels, Translocations, SNV; Missense, Nonsense, CNV, Driver vs. Passenger

2.2.1.1. Mutagens

   2.2.1.1.1. Biological Agents and Cancer

2.2.1.2. Mutation Repair Mechanisms
2.2.1.3. Mutations with Pathological and Non-Pathological Variants

2.3. Major Advances in Precision Medicine

2.3.1. Tumor Biomarkers
2.3.2. Oncogenes and Tumor Suppressor Genes
2.3.3. Diagnostic Biomarkers

2.3.3.1. Resistance
2.3.3.2. Prognosis
2.3.3.3. Pharmaco-Genomics

2.3.4. Cancer Epigenetics

2.4. Main Techniques in the Molecular Biology of Cancer

2.4.1. Cytogenetics and FISH (Fluorescence In Situ Hybridization)
2.4.2. DNA Extract Quality
2.4.3. Liquid Biopsy
2.4.4. PCR as a Basic Molecular Tool
2.4.5. Sequencing, NGS

Module 3. Childhood Malignant Tumors

3.1. The new world of Pediatric and Juvenile Neuropathology and its differences with the adult
3.2. Histomolecular Diagnosis of Medulloblastoma
3.3. Diagnosis of CNS Embryonal Tumors (former PNETs) Beyond the WHO 2016 Classification
3.4. Emerging Entities in the Molecular Classification of Central Nervous System (CNS) Tumors
3.5. Update on CNS Tumor Biomarkers (Adults and Children)
3.6. CNS Pseudotumors

A unique, key, and decisive master’s degree experience to boost your professional development”